Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1349 of 6351
-
New drug QRX-3 aims to speed kidney recovery in hospital patients
Disease control Not yet recruitingUse of QRX-3 in hospitalized patients with pediatric and adult patients with acute tubular necrosis renal failure
Phase 2/3 • Sponsor: Ebima Clifford Okundaye • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Free fruits and veggies prescribed to fight food insecurity and chronic disease
Disease control Not yet recruitingThe goal of this clinical trial is to assess nutrition incentives and produce vouchers to measure the impacts of food insecurity-related chronic health conditions in adults with hypertension and/or diabetes. The main questions it aims to answer are: * Does participation increase…
Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New app aims to help black adults with HIV kick the habit and ease anxiety
Disease control Recruiting nowThe present study aims to investigate the efficacy of an mHealth smoking cessation and HIV disease management intervention among a nationally representative sample of African America/Black (hereafter refer to as Black) persons with HIV/AIDS (PWH) who smoke cigarettes. Participant…
Phase 2 • Sponsor: University of Houston • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug aims to shield cancer patients from chemo side effects
Disease control Recruiting nowThe goal of this clinical trial is to compare the efficacy and safety of trilaciclib versus placebo in subjects with limited stage small cell lung cancer. The main question it aims to answer is: Does trilaciclib have a myeloprotective effect in subject with limited stage small c…
Phase 3 • Sponsor: Pharmacosmos A/S • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug aims to slow kidney damage in rare alport syndrome
Disease control Recruiting nowThis is a randomized, double-Blind, placebo-controlled study to evaluate the efficacy and safety of exaluren in Alport Syndrome patients with nonsense mutations in COL4A3/4/5 genes. Targeted 24 patients aged 12 and older will be enrolled in the trial. The study will be comprise…
Phase 2 • Sponsor: Eloxx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New dosing strategy could mean fewer eye injections for Diabetes-Related vision loss
Disease control Not yet recruitingThe goal of this clinical trial is to understand whether Zhuochuming® (Aflibercept Intravitreal Injection) using a 3 loading doses followed by a treat-and-extend regimen (3+T\&E) can treat patients with diabetic macular edema (DME) who have not received prior treatment. It will a…
Phase 4 • Sponsor: The Third Peoples Hospital of Dalian • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug duo aims to tackle stubborn heart risk factor
Disease control Recruiting nowResearchers designed a trial medicine called MK-7262 to lower levels of Lp(a) in the blood. Researchers want to learn about giving MK-7262 with another trial medicine called enlicitide (also known as MK-0616 or enlicitide decanoate). Enlicitide is in a group of medicines that low…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 10, 2026 05:00 UTC
-
New hope for rare gut tumors? phase 2 trial launches
Disease control Not yet recruitingA phase 2 Study Evaluating the Efficacy and Safety of Single Agent AUR103 Calcium in Patients with Advanced, Well or Moderately differentiated Neuroendocrine Tumours. This is a Proof of Concept (PoC) Phase 2 study of AUR103 calcium in patients with advanced, well or moderately d…
Phase 2 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New pill aims to shed pounds without diabetes
Disease control Not yet recruitingTo evaluate the efficacy of BGM0504 tablets compared with placebo in reducing body weight in overweight or obese participants without diabetes after 20 weeks of treatment.
Phase 2 • Sponsor: BrightGene Bio-Medical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Engineered immune cells take on kidney cancer in first human test
Disease control Recruiting nowThis is a single-arm, open-label, dose-escalating Phase 1 clinical study. It aims to evaluate the safety, tolerability and pharmacokinetic(PK) profiles of the investigational agent, and preliminarily assess its efficacy in subjects with advanced/metastatic renal cell carcinoma, a…
Phase 1 • Sponsor: Hrain Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Strength training and protein diet may reverse frailty in sarcopenic elderly women
Disease control Recruiting nowSixty obese elderly women will be recruited from Fawkia hospital outpatient clinic diagnosed by sarcopenia and randomly allocated into two groups for a 12-week intervention. Patients will be divided into 2 groups (A and B): * Group A (combined intervention group: n=30): will per…
Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
App teaches kids to jump and think — all from home
Knowledge-focused Not yet recruitingThe proposed study uses a mHealth application "app" to help parents teach their preschool-age child motor skill (FMS) activities in the home environment. This app guides families to participate in 10-min activity breaks, 7 days/week for 12 weeks and the app includes weekly instru…
Sponsor: University of Tennessee • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New oral drug aims to cut dangerous COPD exacerbations
Disease control Recruiting nowThis is a Phase 2 study of the efficacy, safety, tolerability and pharmacokinetics of two doses of EXPD-101 in participants with COPD. Study participants will be randomized to receive either study drug or placebo administered once daily for 52 weeks.
Phase 2 • Sponsor: Expedition Therapeutics, Inc • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Wearable sensors give Real-Time feedback to improve gait in children with hemiplegia
Disease control Not yet recruitingThe goal of this clinical trial is to learn about the effect of biofeedback-based inertial sensors gait training on walking parameters in children with hemiplegia. The main question it aims to answer is: Does biofeedback-based inertial sensors gait training have an effect on wal…
Sponsor: Cairo University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
AI coach for parents of autistic kids: could a virtual simulation improve Real-Life communication?
Symptom relief Not yet recruitingThis randomized controlled trial evaluates an AI-based parental simulation designed to support reflective parenting, emotional regulation, and parent-child communication among parents of autistic children aged 3 to 12 years. A total of 140 parents will be recruited through an ext…
Sponsor: University of Haifa • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Old malaria drug may tame lupus skin flares
Disease control Recruiting nowThe research study is being conducted to learn more about how patients with cutaneous lupus erythematosus (CLE) respond to the use of quinacrine. Quinacrine is a medication that was originally developed and used starting in the 1930's to treat malaria. It has been used for decade…
Phase 2 • Sponsor: Victoria Werth • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
PET scan could reveal which breast cancer patients will respond to targeted therapy
Knowledge-focused OngoingThis is a prospective, single-arm, exploratory clinical trial that plans to enroll 40 patients with locally advanced or metastatic breast cancer who are expected to participate in a therapeutic clinical trial of a Nectin-4-targeted agent at our center and receive at least two tre…
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Video analysis could personalize rehab for chemo nerve damage
Symptom relief By invitation onlyThis study aims to quantify motor control abnormalities using video-based movement analysis in patients with chemotherapy-induced peripheral neuropathy (CIPN) and to evaluate the effectiveness of an analysis-guided personalized rehabilitation intervention. The study enrolls adult…
Sponsor: Seoul National University Bundang Hospital • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Could a few minutes of sun each week raise vitamin d and cut infections in kids with cerebral palsy?
Disease control Recruiting nowThe goal of this clinical trial is to learn the effect of sunlight exposure on serum vitamin D levels in children aged 1-5 years with cerebral palsy. This study also aims to assess the effect of sunlight exposure on the incidence of acute respiratory tract infections and to evalu…
Sponsor: Indonesia University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Could cold climates shape heart healing after stents?
Knowledge-focused Recruiting nowThis multicenter prospective observational cohort study aims to investigate the association between cumulative cold-region exposure and adverse left ventricular remodeling and cardiovascular outcomes in patients with coronary artery disease undergoing successful percutaneous coro…
Sponsor: Chinese PLA General Hospital • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC